Funding for this research was provided by:
Received: 26 September 2016
Accepted: 4 April 2018
First Online: 4 May 2018
Ethics approval and consent to participate
: The PACS-01 protocol was reviewed and approved by the French Ethics Committee/Institutional Review Board (CCPPRB of Toulouse, France). Written informed consent was obtained before randomization. The informed consent of the parent PACS-01 trial mentioned that tumoral tissues could be prospectively analyzed for research purpose.
: FLB, JMA, CY, DBC and SS are employees of Genomic Health, Inc. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.